查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1500131

乳房重建市场 - 全球产业规模、份额、趋势、机会和预测，按产品、形状、最终用途、地区和竞争细分，2019-2029F

Breast Reconstruction Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Shape, By End-use, By Region and Competition, 2019-2029F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2023 年全球乳房再造市场价值为4.2839 亿美元，预计在预测期内将稳定增长，到2029 年复合年增长率为6.57%。手术而面临乳房切除术的女性的共鸣。这次復育之旅超越了国界和文化，在全球范围内体现了赋权、疗癒和新的自信。乳房切除术虽然是一种挽救生命的措施，但也会在身体上留下情感上的伤疤。乳房再造在帮助女性重新获得完整感、找回自己的身体和身份方面发挥关键作用。手术的目的是重建乳房的自然轮廓，促进乳房恢復正常并减少损失造成的心理影响。乳房重建提供了一系列选择，以满足个人喜好和需求。两种主要方法包括基于植入物的重建和自体组织重建。

市场概况
预测期 2025-2029
2023 年市场规模 4.2839亿美元
2029 年市场规模 6.2481亿美元
2024-2029 年复合年增长率 6.57%
成长最快的细分市场 植入物
最大的市场 北美洲

以植入物为基础的手术涉及使用硅胶或盐水植入物来重建乳房丘，而自体组织手术则使用患者自己的组织来创造看起来自然的乳房。这些选择使女性能够做出符合其独特情况和期望结果的决定。乳房重建远远超出了物理修復的范围。它对情绪健康、自信和整体生活品质有着深远的影响。女性经常表示身体形象、自尊心和对生活的掌控感得到了改善。透过解决可见和不可见的疤痕，乳房重建可以促进情绪癒合，并帮助女性以新的自豪感拥抱自己的身体。乳房重建是一项涉及熟练外科医生、医疗专业人员和富有同情心的支持网络的协作努力。外科医生与患者密切合作，了解他们的目标、担忧和病史。乳房再造市场的新兴趋势是教育资源的扩散。宣传活动和讯息传播为女性提供了关于乳房切除术后选择做出明智决定的工具。这种赋权使女性能够积极参与康復之旅，促进身心健康。

主要市场驱动因素

乳癌发生率增加

自体组织重建的需求增加

不断成长的植入创新

主要市场挑战

意识和教育差距

财务障碍

获得熟练外科医生的机会有限

主要市场趋势

微创手术的增加

细分市场洞察

产品洞察

最终用途见解

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球乳房重建市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 副产品（植入物{硅胶乳房植入物、盐水乳房植入物}、组织扩张器{组织扩张器、盐水扩张器、空气组织扩张器}）
    • 按形状（圆形，解剖学）
    • 依最终用途（医院、美容诊所）
    • 按公司划分 (2023)
    • 按地区
  • 市场地图

第 6 章：北美乳房重建市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按形状
    • 按最终用途
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章：欧洲乳房重建市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 按形状
    • 按最终用途
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区乳房重建市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 按形状
    • 按最终用途
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第 9 章：南美洲乳房重建市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按形状
    • 按最终用途
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲乳房再造市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品分类
    • 按形状
    • 按最终用途
    • 按国家/地区
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 最近的发展
  • 产品发布
  • 併购

第 13 章：大环境分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • Abbvie Inc.
  • Medical Device Business Services, Inc.
  • Sientra, Inc.
  • Integra LifeSciencs Corporation
  • Stryker Corporation
  • RTI Surgical Inc.
  • TELA Bio, Inc.
  • Establishment Labs SA
  • Holigic, Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 23953

Global Breast Reconstruction Market was valued at USD 428.39 Million in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 6.57% through 2029. Breast reconstruction is a transformative aspect of healthcare that resonates with women worldwide who have faced mastectomy due to breast cancer or other medical reasons. This restorative journey transcends borders and cultures, embodying empowerment, healing, and renewed self-confidence on a global scale. Mastectomy, while a life-saving measure, can leave emotional scars along with physical ones. Breast reconstruction plays a pivotal role in helping women regain a sense of wholeness, allowing them to reclaim their bodies and identities. The procedure aims to recreate the breast's natural contours, facilitating a return to normalcy and reducing the psychological impact of the loss. Breast reconstruction offers a range of choices to cater to individual preferences and needs. Two primary approaches include implant-based reconstruction and autologous tissue reconstruction.

Market Overview
Forecast Period2025-2029
Market Size 2023USD 428.39 Million
Market Size 2029USD 624.81 Million
CAGR 2024-20296.57%
Fastest Growing SegmentImplants
Largest MarketNorth America

Implant-based procedures involve using silicone or saline implants to recreate the breast mound, while autologous tissue procedures use the patient's own tissue to craft a natural-looking breast. These choices empower women to make decisions that align with their unique circumstances and desired outcomes. Breast reconstruction extends far beyond physical restoration. It has a profound impact on emotional well-being, self-confidence, and overall quality of life. Women often report improved body image, self-esteem, and a renewed sense of control over their lives. By addressing both the visible and invisible scars, breast reconstruction nurtures emotional healing and helps women embrace their bodies with newfound pride. Breast reconstruction is a collaborative effort involving skilled surgeons, medical professionals, and compassionate support networks. Surgeons work closely with patients to understand their goals, concerns, and medical history. An emerging trend within the breast reconstruction market is the proliferation of educational resources. Awareness campaigns and information dissemination have given women the tools to make informed decisions about their post-mastectomy choices. This empowerment enables women to actively engage in their recovery journey, promoting physical and psychological well-being.

Key Market Drivers

Increasing Breast Cancer Incidence

Breast cancer, a prevalent global health concern, has not only spurred advances in treatment but also fueled the growth of the breast reconstruction industry. The increasing incidence of breast cancer diagnoses is a driving force behind the expansion of breast reconstruction procedures, offering women a chance to restore not only their physical appearance but also their emotional well-being. Breast cancer, one of the most prevalent cancers affecting women globally, continues to pose a significant challenge to public health. The alarming trend of increasing breast cancer incidence has brought this disease to the forefront of medical attention, urging societies to prioritize awareness, early detection, and robust healthcare strategies. According to the World Health Organization (WHO), breast cancer is the most common cancer among women, both in developed and developing countries. The increasing breast cancer incidence can be attributed to various factors aging population, lifestyle changes, environmental exposures, genetic and hormonal factors, etc. The aging global population plays a role in the rising incidence, as age is a significant risk factor for breast cancer. Modern lifestyles, characterized by poor dietary habits, sedentary routines, and stress, contribute to an increased risk of breast cancer. Exposure to environmental pollutants and chemicals may play a role in the development of breast cancer. Beyond physical restoration, breast reconstruction plays a crucial role in psychological healing. The procedure contributes to improved self-esteem, body image, and overall well-being, aiding in the emotional recovery from the trauma of breast cancer diagnosis and treatment.

Rise in demand for Autologous Tissue Reconstruction

Breast reconstruction has witnessed a paradigm shift in recent years, with autologous tissue reconstruction emerging as a significant driver behind the increased demand for breast reconstruction. This innovative approach, which involves using a patient's own tissue to rebuild the breast, has not only reshaped the possibilities of surgical outcomes but has also become a powerful catalyst for more women seeking post-mastectomy rejuvenation. Autologous tissue reconstruction stands out for its natural-looking results and long-lasting benefits. Unlike traditional methods that rely on implants, this technique employs a patient's own tissue, typically harvested from areas like the abdomen, buttocks, or thighs. This not only creates a more harmonious and authentic appearance but also ensures that the reconstructed breast evolves naturally with the body over time. One of the key reasons behind the growing demand for autologous tissue reconstruction is its potential to address concerns related to implant-based procedures. While implants have their advantages, they might not suit everyone due to factors such as implant rupture, implant-related complications, and the need for periodic replacements. Autologous tissue reconstruction offers a more durable and biocompatible alternative, alleviating these concerns and contributing to greater peace of mind for patients. This technique can lead to secondary benefits such as improved body contouring in the donor site, effectively combining reconstructive surgery with cosmetic enhancements. Patients can not only regain a sense of wholeness but also achieve a more sculpted silhouette, enhancing their overall self-esteem and body image. The personalized nature of autologous tissue reconstruction also contributes to its appeal. Surgeons can tailor the procedure to match the patient's individual anatomy, resulting in breasts that feel and move naturally. This customization not only boosts aesthetic outcomes but also ensures a higher level of patient satisfaction.

Growing Implant Innovations

Breast reconstruction surgery has witnessed a remarkable transformation over the years, largely driven by innovative advancements in implant technology. Implant advancements have not only revolutionized the surgical landscape but have also significantly increased the demand for breast reconstruction procedures. Traditionally, breast reconstruction was a complex and often lengthy process, involving multiple surgeries and lengthy recovery periods. However, recent implant innovations have changed the process, providing more efficient and aesthetically pleasing outcomes for patients. The introduction of advanced implant materials, such as cohesive silicone gel and saline-filled implants, has offered greater flexibility to reconstructive surgeons, allowing them to tailor procedures to individual patient needs. One of the most prominent developments is the advent of personalized implants. These implants can be customized to match the patient's unique anatomy, ensuring a natural look and feel. 3D imaging and printing technologies have made it possible to create implants that align perfectly with the remaining breast tissue, resulting in improved symmetry and overall patient satisfaction. The refinement of surgical techniques, such as prepectoral placement (placing implants above the chest muscle) and nipple-sparing mastectomy, has led to reduced surgical complexity and faster recovery times. This has not only attracted more patients to consider breast reconstruction but has also encouraged those who might have been hesitant due to concerns about the surgical process. The psychological impact of breast reconstruction cannot be underestimated. For many women, the procedure goes beyond physical restoration, contributing to emotional healing and a renewed sense of confidence and self-esteem. The availability of innovative implant options has made these positive outcomes more attainable, driving an increasing number of women to explore breast reconstruction as a viable option after mastectomy. As technology continues to advance, patients can expect even more refined and personalized options, making the journey from diagnosis to recovery more manageable and empowering.

Key Market Challenges

Awareness and Education Gap

A significant challenge is the lack of awareness among patients and even healthcare professionals about the options available for breast reconstruction. Women who undergo mastectomy might not be informed about the possibility of simultaneous reconstruction, leading to missed opportunities for optimal results. Bridging this information gap requires concerted efforts from medical professionals, advocacy groups, and awareness campaigns to ensure that patients are well-informed about their choices. Dressing the lack of awareness surrounding breast reconstruction options is an essential step towards providing comprehensive care to mastectomy patients. Through collaborative efforts of medical professionals, advocacy groups, and awareness campaigns, the journey towards healing can become more informed, enabling women to make choices that align with their preferences, values, and desired outcomes.

Financial Barriers

The cost associated with breast reconstruction can be a deterrent for many patients. While insurance often covers reconstruction, navigating the complexities of coverage, potential out-of-pocket expenses, and financial uncertainties can be overwhelming. Patients may forego the procedure due to financial concerns, necessitating more transparent communication about costs, insurance coverage, and financial assistance programs. While insurance policies often cover the core aspects of breast reconstruction, navigating the fine print and deciphering terms can be perplexing. This confusion can lead to apprehension and hesitation on the part of patients, as they might worry about unexpected expenses or hidden costs.

Limited Access to Skilled Surgeons

Access to skilled surgeons and specialized facilities can be unevenly distributed across regions, leading to disparities in the quality of care and outcomes. Rural or underserved areas may lack the resources necessary for breast reconstruction procedures. Efforts to expand the availability of well-trained professionals and state-of-the-art facilities can help bridge this gap and ensure consistent access to high-quality reconstruction options. The quest for optimal breast reconstruction outcomes should not be hindered by geographical location. However, the reality is that access to specialized surgeons and advanced facilities is not evenly distributed. Rural and underserved areas, which might already face limited healthcare resources, suffer the most from this imbalance. Patients in these regions often must travel long distances to access qualified professionals, which can lead to delays in treatment, compromised follow-up care, and overall reduced satisfaction with the reconstruction process.

Key Market Trends

Rise in Minimally Invasive Procedures

Surgeons are increasingly tailoring procedures to each patient's unique anatomy, desires, and aesthetic preferences. This involves using 3D imaging, computer simulations, and advanced materials to create breast reconstructions that align seamlessly with the patient's body, ensuring natural-looking results and higher patient satisfaction. Minimally invasive techniques are making their mark in breast reconstruction. These procedures often result in smaller incisions, reduced scarring, and quicker recovery times. Fat grafting, in which a patient's own fat is harvested and used for reconstruction, is a prime example. This trend aligns with the growing preference for less invasive surgeries and underscores the importance of patient comfort and convenience. A significant factor in the realm of minimally invasive breast reconstruction is fat grafting, also known as autologous fat transfer. This procedure involves harvesting fat cells from one part of the patient's body, such as the abdomen or thighs, and then carefully injecting them into the breast area to restore volume and contour. This technique not only creates a natural appearance but also harnesses the body's own resources for reconstruction. The popularity of fat grafting stems from its numerous advantages. Smaller incisions mean less tissue trauma, leading to reduced scarring and discomfort. Patients often experience shorter recovery times compared to traditional reconstruction methods. Since the procedure utilizes the patient's own fat cells, the risk of allergic reactions or foreign body complications is minimal. The rise of minimally invasive techniques aligns seamlessly with the growing preference for patient-centric care. Patients today prioritize treatments that not only deliver effective results but also prioritize their well-being. The convenience of shorter recovery times and reduced discomfort resonates deeply with individuals seeking post-mastectomy rejuvenation.

Segmental Insights

Product Insights

Based on Product, Implants have emerged as the fastest growing segment in the Global Breast Reconstruction Market in 2023. Breast implants have long been a popular choice for individuals seeking breast augmentation procedures, driving the substantial market share held by this segment. The preference for breast implants can be attributed to various factors, including advancements in implant technology, improved surgical techniques, and shifting societal norms regarding body aesthetics. One key driver behind the growth of the implants segment is the increasing number of individuals opting for breast augmentation procedures. Over the years, there has been a growing cultural acceptance and normalization of cosmetic surgery, contributing to the rising demand for breast implants. Factors such as the desire for enhanced self-esteem, body confidence, and aesthetic appeal have fueled the popularity of breast augmentation surgeries, thereby driving the expansion of the implants market within the broader Breast Reconstruction Market.

End-Use Insights

Based on End-use, Hospitals have emerged as the dominating segment in the Global Breast Reconstruction Market in 2023. The increasing number of hospitals worldwide contributes significantly to the segment's growth trajectory. With growing populations and rising healthcare needs, there is a continuous demand for healthcare facilities equipped to handle a variety of medical procedures, including breast reconstruction. Hospitals, with their infrastructure, specialized departments, and skilled medical personnel, are ideally positioned to cater to this demand and perform breast reconstruction surgeries effectively. The expansion of diagnostic and screening procedures further fuels the growth of the hospitals segment in the Breast Reconstruction Market. As awareness about breast cancer and related conditions grows, more individuals are undergoing screenings and diagnostic tests to detect and address potential issues at an early stage. Hospitals play a crucial role in providing these diagnostic services and subsequently offering comprehensive treatment options, including breast reconstruction, to patients in need.

Regional Insights

Based on Region, North America have emerged as the dominating region in the Global Breast Reconstruction Market in 2023. One of the primary contributors to North America's dominance is the significant number of breast cancer patients in this region. Breast cancer remains one of the most prevalent forms of cancer among women in North America, prompting a high demand for breast reconstruction procedures to restore the physical appearance and confidence of affected individuals. The region's advanced healthcare infrastructure, coupled with widespread access to specialized medical facilities and skilled healthcare professionals, further bolsters its leadership in the Breast Reconstruction Market.

Key Market Players

AbbVie Inc.

Medical Device Business Services, Inc.

Sientra, Inc.

Integra LifeSciences Corporation

Stryker Corporation

RTI Surgical Inc.

TELA Bio, Inc.

Establishment Labs S.A.

Hologic, Inc.

Report Scope:

In this report, the Global Breast Reconstruction Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Breast Reconstruction Market, By Product:

    Implants
    • Silicone Breast Implants
    • Saline Breast Implants
    Tissue Expander
    • Tissue Expander
    • Saline Expander
    • Air Tissue Expander

Breast Reconstruction Market, By Shape:

    Round Anatomical

Breast Reconstruction Market, By End-use:

    Hospitals Cosmetology Clinics

Breast Reconstruction Market, By Region:

    North America
    • United States
    • Canada
    • Mexico
    Asia Pacific
    • China
    • India
    • South Korea
    • Australia
    • Japan
    Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
    South America
    • Brazil
    • Argentina
    • Colombia
    Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Breast Reconstruction Market.

Available Customizations:

Global Breast Reconstruction Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Breast Reconstruction Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Implants {Silicone Breast Implants, Saline Breast Implants}, Tissue Expander {Tissue Expander, Saline Expander, Air Tissue Expander})
    • 5.2.2. By Shape (Round, Anatomical)
    • 5.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 5.2.4. By Company (2023)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Breast Reconstruction Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Implants, Tissue Expander)
    • 6.2.2. By Shape (Round, Anatomical)
    • 6.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Breast Reconstruction Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product (Implants, Tissue Expander)
        • 6.3.1.2.2. By Shape (Round, Anatomical)
        • 6.3.1.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 6.3.2. Mexico Breast Reconstruction Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product (Implants, Tissue Expander)
        • 6.3.2.2.2. By Shape (Round, Anatomical)
        • 6.3.2.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 6.3.3. Canada Breast Reconstruction Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product (Implants, Tissue Expander)
        • 6.3.3.2.2. By Shape (Round, Anatomical)
        • 6.3.3.2.3. By End-use (Hospitals, Cosmetology Clinics)

7. Europe Breast Reconstruction Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Implants, Tissue Expander)
    • 7.2.2. By Shape (Round, Anatomical)
    • 7.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Breast Reconstruction Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product (Implants, Tissue Expander)
        • 7.3.1.2.2. By Shape (Round, Anatomical)
        • 7.3.1.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 7.3.2. Germany Breast Reconstruction Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product (Implants, Tissue Expander)
        • 7.3.2.2.2. By Shape (Round, Anatomical)
        • 7.3.2.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 7.3.3. United Kingdom Breast Reconstruction Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product (Implants, Tissue Expander)
        • 7.3.3.2.2. By Shape (Round, Anatomical)
        • 7.3.3.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 7.3.4. Italy Breast Reconstruction Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product (Implants, Tissue Expander)
        • 7.3.4.2.2. By Shape (Round, Anatomical)
        • 7.3.4.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 7.3.5. Spain Breast Reconstruction Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product (Implants, Tissue Expander)
        • 7.3.5.2.2. By Shape (Round, Anatomical)
        • 7.3.5.2.3. By End-use (Hospitals, Cosmetology Clinics)

8. Asia Pacific Breast Reconstruction Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Implants, Tissue Expander)
    • 8.2.2. By Shape (Round, Anatomical)
    • 8.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 8.2.4. By Country
  • 8.3. AsiaPacific: Country Analysis
    • 8.3.1. China Breast Reconstruction Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product (Implants, Tissue Expander)
        • 8.3.1.2.2. By Shape (Round, Anatomical)
        • 8.3.1.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 8.3.2. India Breast Reconstruction Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product (Implants, Tissue Expander)
        • 8.3.2.2.2. By Shape (Round, Anatomical)
        • 8.3.2.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 8.3.3. South Korea Breast Reconstruction Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product (Implants, Tissue Expander)
        • 8.3.3.2.2. By Shape (Round, Anatomical)
        • 8.3.3.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 8.3.4. Japan Breast Reconstruction Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product (Implants, Tissue Expander)
        • 8.3.4.2.2. By Shape (Round, Anatomical)
        • 8.3.4.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 8.3.5. Australia Breast Reconstruction Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product (Implants, Tissue Expander)
        • 8.3.5.2.2. By Shape (Round, Anatomical)
        • 8.3.5.2.3. By End-use (Hospitals, Cosmetology Clinics)

9. South America Breast Reconstruction Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Implants, Tissue Expander)
    • 9.2.2. By Shape (Round, Anatomical)
    • 9.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Breast Reconstruction Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product (Implants, Tissue Expander)
        • 9.3.1.2.2. By Shape (Round, Anatomical)
        • 9.3.1.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 9.3.2. Argentina Breast Reconstruction Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product (Implants, Tissue Expander)
        • 9.3.2.2.2. By Shape (Round, Anatomical)
        • 9.3.2.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 9.3.3. Colombia Breast Reconstruction Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product (Implants, Tissue Expander)
        • 9.3.3.2.2. By Shape (Round, Anatomical)
        • 9.3.3.2.3. By End-use (Hospitals, Cosmetology Clinics)

10. Middle East and Africa Breast Reconstruction Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Implants, Tissue Expander)
    • 10.2.2. By Shape (Round, Anatomical)
    • 10.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Breast Reconstruction Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product (Implants, Tissue Expander)
        • 10.3.1.2.2. By Shape (Round, Anatomical)
        • 10.3.1.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 10.3.2. Saudi Arabia Breast Reconstruction Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product (Implants, Tissue Expander)
        • 10.3.2.2.2. By Shape (Round, Anatomical)
        • 10.3.2.2.3. By End-use (Hospitals, Cosmetology Clinics)
    • 10.3.3. UAE Breast Reconstruction Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product (Implants, Tissue Expander)
        • 10.3.3.2.2. By Shape (Round, Anatomical)
        • 10.3.3.2.3. By End-use (Hospitals, Cosmetology Clinics)

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Abbvie Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Medical Device Business Services, Inc.
  • 15.3. Sientra, Inc.
  • 15.4. Integra LifeSciencs Corporation
  • 15.5. Stryker Corporation
  • 15.6. RTI Surgical Inc.
  • 15.7. TELA Bio, Inc.
  • 15.8. Establishment Labs S.A.
  • 15.9. Holigic, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer